EFPIA highlights inequalities in patient access around Europe
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released the results of its annual survey on patient access. … read more »
BPI looks forward to German EU Presidency
The German industry body Bundesverband der Pharmazeutischen Industrie e.V. (BPI) has published its thoughts ahead of the new EU Presidency. … read more »
Survey on centrally authorised products in the EU
The European Commission (EC) has launched a survey for feedback on a pilot programme to improve pan-European access to medicines. … read more »
Industry bodies call for UK-EU MRA
Influential European industry groups have written to the three European Presidents, the Commissioner for Trade, and the Chief Negotiator for … read more »
EFPIA looks to future EU collaborations after coronavirus
The pharmaceutical industry body in Europe, EFPIA, has looked to a post-COVID-19 world, and focussed on how Member States can … read more »
EU states seek secure COVID-19 vaccine supply
An intergovernmental agreement between EU Member States has been developed to accelerate the search for a coronavirus vaccine, coinciding with … read more »
Coronavirus triggers medicine shortages and restrictions
The European Medicines Agency (EMA) is reporting shortages of certain medicines in certain Member States. Bodies such as the UK’s … read more »
EMA statement clarifies Brexit situation
The European Medicines Agency (EMA) has released a statement to mark the start of the transition period between the UK … read more »
Medicines shortages: EU supply chain stakeholders issue paper calling for dialogue
Seven European institutions from across the cycle of medicines’ supply chain have called for dialogue “addressing the root causes of … read more »
No-Deal Brexit: Government announces minimum 6 month healthcare coverage for UK nationals living in the EU
The UK Government has confirmed that if the UK leaves the EU without a deal on 31st October 2019, it … read more »
